News
-
-
-
COMMUNIQUÉ DE PRESSE
Jaguar Health Provides Update on Meeting with FDA Discussing Statistically Significant Results of Responder Analysis of Breast Cancer Patients in Phase 3 OnTarget Trial and Potential Approval Pathway for Crofelemer
Jaguar Health's Napo Pharmaceuticals shares plans to seek approval for crofelemer in cancer therapy-related diarrhea for metastatic breast cancer patients. Key discussions with FDA highlighted in Type C Meeting -
-
COMMUNIQUÉ DE PRESSE
New to The Street's Documentary Specials Break Records: IMG Academy Surpasses 126,000 Views in Just 12 Days
New to The Street's long-form corporate storytelling programs featuring PetVivo and Acurx Pharmaceuticals exceed 200,000 views, establishing as a leading platform for investor-focused content -
-
COMMUNIQUÉ DE PRESSE
Abasca Resources Announces Newly Discovered Thor Graphite Zone Parallel to its Loki Flake Graphite Deposit and Closing of the Final Tranche of Its Private Placement
Abasca Resources Inc. releases assay results confirming graphite mineralization at the Key Lake South Project's Thor Graphite Zone. Finalizes non-brokered private placement. Details on the offering and related party transactions disclosed -
-
-
